How Targeted Cancer Drugs Disrupt the Cell Cycle
PLOS: DNA Science
JUNE 22, 2023
After passing safety tests, Gleevec worked so well that it set a new record for drug approval—10 weeks, on May 10, 2001. I had the privilege to meet one of the first people to receive Gleevec, which I wrote about for Bioethics Today in 2006. Like Erin, they had CML.
52 
Let's personalize your content